• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma.

作者信息

Nadiminti Kalyan, Sidiqi M Hasib, Meleveedu Kapil, Alkhateeb Hassan B, Hogan William J, Litzow Mark, Patnaik Mrinal, Kumar Shaji, Gertz Morie, Chen Dong, Shah Mithun Vinod

机构信息

Division of Hematology, Mayo Clinic, Rochester, MN, USA.

Division of Hematology, Oncology, and Palliative Care, University of Wisconsin, Madison, WI, USA.

出版信息

Blood Cancer J. 2021 Mar 19;11(3):63. doi: 10.1038/s41408-021-00454-y.

DOI:10.1038/s41408-021-00454-y
PMID:33741897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7979889/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131f/7979889/c1d90f33ae93/41408_2021_454_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131f/7979889/c1d90f33ae93/41408_2021_454_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131f/7979889/c1d90f33ae93/41408_2021_454_Fig1_HTML.jpg

相似文献

1
Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma.多发性骨髓瘤自体干细胞移植后治疗相关髓系肿瘤的特征与转归
Blood Cancer J. 2021 Mar 19;11(3):63. doi: 10.1038/s41408-021-00454-y.
2
Myelodysplastic syndromes complicating hematopoietic stem cell transplantation.造血干细胞移植相关的骨髓增生异常综合征
Cancer Treat Res. 2001;108:169-84. doi: 10.1007/978-1-4615-1463-3_10.
3
Characteristics and outcomes of therapy-related myeloid neoplasms after treatment for multiple myeloma.多发性骨髓瘤治疗后治疗相关髓系肿瘤的特征与转归
Leuk Lymphoma. 2019 Dec;60(14):3577-3580. doi: 10.1080/10428194.2019.1633639. Epub 2019 Jul 8.
4
Incidence and characterization of secondary myelodysplastic syndromes following autologous transplantation.自体移植后继发性骨髓增生异常综合征的发病率及特征
Haematologica. 2000 Apr;85(4):403-9.
5
Secondary acute myeloid leukemia and myelodysplasia after autologous peripheral blood progenitor cell transplantation.自体外周血祖细胞移植后的继发性急性髓系白血病和骨髓增生异常综合征
Ann Hematol. 2002 Jan;81(1):11-5. doi: 10.1007/s00277-001-0400-0. Epub 2001 Dec 8.
6
Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma.非霍奇金淋巴瘤大剂量治疗及自体骨髓移植后发生治疗相关骨髓增生异常综合征/急性白血病的风险
Ann Oncol. 2002 Mar;13(3):450-9. doi: 10.1093/annonc/mdf109.
7
Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Patients with Myeloma in the Era of Novel Therapies.新型疗法时代多发性骨髓瘤患者治疗相关髓系肿瘤的临床病理特征。
Mod Pathol. 2023 Jun;36(6):100166. doi: 10.1016/j.modpat.2023.100166. Epub 2023 Mar 27.
8
Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma.惰性非霍奇金淋巴瘤治疗后的继发性恶性肿瘤
Haematologica. 2008 Mar;93(3):336-8. doi: 10.3324/haematol.12585.
9
[Stem cells in hematology and oncology].[血液学与肿瘤学中的干细胞]
Med Klin (Munich). 2003 Dec 15;98 Suppl 2:11-4.
10
Allogeneic stem cell transplantation in therapy-related acute myeloid leukemia and myelodysplastic syndromes: impact of patient characteristics and timing of transplant.同种异体造血干细胞移植治疗相关性急性髓系白血病和骨髓增生异常综合征：患者特征和移植时机的影响。
Leuk Lymphoma. 2012 Jan;53(1):96-102. doi: 10.3109/10428194.2011.603445. Epub 2011 Aug 24.

引用本文的文献

1
Allogeneic hematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for multiple myeloma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.异基因造血细胞移植治疗多发性骨髓瘤治疗后发生的治疗相关髓系肿瘤：一项代表欧洲血液与骨髓移植协会慢性恶性肿瘤工作组的回顾性研究
Bone Marrow Transplant. 2025 Feb;60(2):220-226. doi: 10.1038/s41409-024-02462-5. Epub 2024 Nov 12.
2
Characteristics and outcomes of therapy-related acute leukemia following autologous transplant (Auto-HCT) for multiple myeloma.多发性骨髓瘤自体移植（Auto-HCT）后治疗相关急性白血病的特征与转归
Bone Marrow Transplant. 2025 Jan;60(1):64-68. doi: 10.1038/s41409-024-02455-4. Epub 2024 Oct 30.
3

本文引用的文献

1
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant.克隆性造血与接受移植的多发性骨髓瘤患者的不良结局相关。
Nat Commun. 2020 Jun 12;11(1):2996. doi: 10.1038/s41467-020-16805-5.
2
Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma.新诊断多发性骨髓瘤患者病态造血的生物学和临床意义。
Blood. 2020 Jun 25;135(26):2375-2387. doi: 10.1182/blood.2019003382.
3
Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing.
Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment.治疗相关髓系肿瘤：细胞毒性治疗、遗传因素和异常微环境之间的复杂相互作用。
Blood Cancer Discov. 2024 Nov 1;5(6):400-416. doi: 10.1158/2643-3230.BCD-24-0103.
4
Myeloid neoplasm post cytotoxic treatment in patients with multiple myeloma.多发性骨髓瘤患者接受细胞毒性治疗后的髓系肿瘤
EJHaem. 2024 Sep 30;5(5):1089-1091. doi: 10.1002/jha2.1017. eCollection 2024 Oct.
5
Clonal hematopoiesis-derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders.自体造血干细胞移植治疗淋巴和非淋巴系统疾病后，由克隆性造血衍生的治疗相关髓系肿瘤。
Leukemia. 2024 Jun;38(6):1266-1274. doi: 10.1038/s41375-024-02258-y. Epub 2024 Apr 29.
6
International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update.国际移植和细胞治疗长期幸存者的筛查和预防建议：2023 年更新版。
Bone Marrow Transplant. 2024 Jun;59(6):717-741. doi: 10.1038/s41409-023-02190-2. Epub 2024 Feb 27.
7
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update.国际移植和细胞治疗长期幸存者筛查和预防建议：2023 年更新版。
Transplant Cell Ther. 2024 Apr;30(4):349-385. doi: 10.1016/j.jtct.2023.12.001. Epub 2024 Feb 27.
8
Small myeloid subclones are present at diagnosis of multiple myeloma in patients who develop secondary myelodysplastic syndromes.在发展为继发性骨髓增生异常综合征的患者中，多发性骨髓瘤诊断时存在小的髓系亚克隆。
Haematologica. 2024 Apr 1;109(4):1289-1292. doi: 10.3324/haematol.2023.284050.
9
The immunome of mobilized peripheral blood stem cells is predictive of long-term outcomes and therapy-related myeloid neoplasms in patients with multiple myeloma undergoing autologous stem cell transplant.动员外周血造血干细胞的免疫组学可预测多发性骨髓瘤患者自体造血干细胞移植后长期结局和治疗相关髓系肿瘤。
Blood Cancer J. 2023 Sep 26;13(1):151. doi: 10.1038/s41408-023-00920-9.
10
Single-agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.初诊多发性骨髓瘤患者自体造血干细胞移植后单用来那度胺维持治疗：MD 安德森的经验。
Am J Hematol. 2023 Oct;98(10):1571-1578. doi: 10.1002/ajh.27029. Epub 2023 Jul 17.
一线自体移植在多发性骨髓瘤中的利弊：时机之争。
Blood. 2019 Feb 14;133(7):652-659. doi: 10.1182/blood-2018-08-825349. Epub 2018 Dec 26.
4
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma.淋巴瘤和浆细胞骨髓瘤自体移植后发生急性髓系白血病和骨髓增生异常综合征的风险。
Leuk Res. 2018 Nov;74:130-136. doi: 10.1016/j.leukres.2018.07.016. Epub 2018 Jul 19.
5
Acute Erythroleukemias, Acute Megakaryoblastic Leukemias, and Reactive Mimics: A Guide to a Number of Perplexing Entities.急性红白血病、急性巨核细胞白血病及反应性模仿病变：若干复杂实体的指南
Am J Clin Pathol. 2015 Jul;144(1):44-60. doi: 10.1309/AJCPRKYAT6EZQHC7.
6
Therapy-related myelodysplastic syndrome/acute leukemia after multiple myeloma in the era of novel agents.新型药物时代多发性骨髓瘤后与治疗相关的骨髓增生异常综合征/急性白血病
Leuk Lymphoma. 2015 Jun;56(6):1723-6. doi: 10.3109/10428194.2014.970543. Epub 2014 Nov 3.
7
Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma.来那度胺联合地塞米松治疗不适合移植的骨髓瘤患者。
N Engl J Med. 2014 Sep 4;371(10):906-17. doi: 10.1056/NEJMoa1402551.
8
Characteristics and outcomes of patients with multiple myeloma who develop therapy-related myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia.发生治疗相关骨髓增生异常综合征、慢性粒单核细胞白血病或急性髓系白血病的多发性骨髓瘤患者的特征及预后
Clin Lymphoma Myeloma Leuk. 2015 Feb;15(2):110-4. doi: 10.1016/j.clml.2014.07.001. Epub 2014 Jul 15.
9
Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data.来那度胺治疗初诊多发性骨髓瘤的第二原发恶性肿瘤：一项个体患者数据的荟萃分析。
Lancet Oncol. 2014 Mar;15(3):333-42. doi: 10.1016/S1470-2045(13)70609-0. Epub 2014 Feb 11.
10
Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients.意义未明的单克隆丙种球蛋白血症（MGUS）患者发生急性白血病和骨髓增生异常综合征的风险：对 17315 例患者的基于人群的研究。
Leukemia. 2013 Jun;27(6):1391-3. doi: 10.1038/leu.2013.34. Epub 2013 Feb 5.